RT Generic
T1 Stereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patients
A1 Morales-Orue, Ignacio
A1 Zafra-Martin, Juan
A1 Garcia, Laura
A1 Chicas-Sett, Rodolfo
A1 Castilla-Martinez, Juan
A1 Auxiliadora Cabezon, Maria
A1 Burgos, Javier
A1 Lloret, Marta
A1 Lara, Pedro C.
K1 Stereotactic ablative radiotherapy (SABR)
K1 elderly
K1 oligometastatic
K1 radiotherapy
K1 breast
K1 Body radiation-therapy
K1 Quality-of-life
K1 Brain metastases
K1 Combination chemotherapy
K1 International society
K1 Geriatric assessment
K1 Follow-up
K1 Radiosurgery
K1 Oncology
K1 Sbrt
AB Breast cancer (BC) is the principal cause of cancer-related death in women. Metastatic patients are usually treated with a systemic therapy, but clinical results are limited. Oligometastatic subjects can benefit from high-precision radiotherapy techniques to potentially achieve a complete response. Currently, there is limited evidence of stereotactic ablative radiotherapy (SABR) treatments in elderly oligometastatic cancer patients. A review of the medical literature was performed in PubMed database to assess the current role of SABR in the treatment of breast oligometastases in elderly patients. SABR represents a feasible and safe therapeutic approach in oligometastatic elderly BC patients. Further studies are required to establish the optimum patient selection and treatment scheme.
PB Ame publishing company
SN 2218-676X
YR 2020
FD 2020-01-01
LK https://hdl.handle.net/10668/25001
UL https://hdl.handle.net/10668/25001
LA en
DS RISalud
RD Apr 7, 2025